止痛药输液帮浦市场（按产品、应用和地区划分）2024 年至 2031 年

止痛药输液帮浦市场评估，2024-2031

2023 年止痛药输液帮浦市场规模价值 27.5 亿美元。输液帮浦是癌症、糖尿病等慢性疾病患者常用来克服输送相关问题的医疗设备。

老年人慢性疼痛的增加、手术过程中疼痛管理的需求不断增加以及全球手术数量的增加，正在推动对止痛药输液帮浦的需求激增。因此，预计目前市场从 2024 年到 2031 年的复合年增长率约为 5.3%，到 2031 年市场规模达到 30.5 亿美元。

止痛药输液帮浦市场定义/概述

止痛药输液帮浦是一种用于将止痛药直接输送到患者体内的医疗设备。透过提供一致且精确的止痛药流，这些帮浦可以有效地控制疼痛并改善患者的生活品质。这些解决方案对于产科、末期疾病、术后和创伤患者特别有用。此帮浦可编程为在一段时间内施用特定剂量，确保稳定释放止痛药。

慢性疼痛的盛行率在所有年龄层中，尤其是老年族群呈现上升趋势，包括由慢性下背痛症候群、复杂性局部疼痛症候群（CRPS）、心肌梗塞、脊髓损伤和脑性麻痹引起的疼痛。

推动输液帮浦采用的因素有哪些？

慢性疼痛，如关节炎、癌症疼痛和神经性疼痛，在全世界肥胖、老年人和其他年龄群体中越来越普遍，对疼痛管理方案的需求也随之增加。需求也日益增加泵浦。同样，手术后缓解疼痛的药物注射器的需求也为止痛药输液帮浦市场创造了空间。

此外，透过使用人工智慧和互联健康平台等智慧功能，精确剂量控制和远端监控等持续进步都成为可能，促进了便携式、用户友好型解决方案的开发。因此，泵浦技术的改进正在提高止痛药输液帮浦的功能和使用者体验。

此外，由于提供治疗效益和患者满意度的措施和教育活动，类似这些帮浦的有效疼痛管理解决方案的采用正在增加。人们越来越意识到在家庭保健和门诊手术中心使用止痛药输液帮浦可以减少住院时间并使疼痛管理个人化。

此外，新兴经济体的高可支配收入也推动了销售，因为它改善了获得医疗服务和先进医疗技术（如止痛药输液泵）的机会。

儘管成本高昂且监管障碍重重，但止痛药输液帮浦市场预计在未来几年仍将继续成长。

高成本会阻碍止痛药输液帮浦市场的成长吗？

开发和维护技术先进的输液帮浦的成本会影响医疗机构的采用率，特别是在资源贫乏和低收入的机构。这是因为所使用的针头和注射器进一步增加了整体成本，并可能阻止患者获得先进的治疗选择。

医疗设备受到严格的监管要求，这可能会延长审批时间并增加开发成本，从而减慢上市时间。这笔财务支出很可能落在製造商和医疗保健提供者的身上。

虽然口服药物、神经阻断等非侵入性技术以及物理治疗等替代性疼痛管理方法已被证明是有效的，但泵在某些情况下可能具有优势，并且可能引起医疗保健专业人员的担忧。

也需要进行适当的训练以避免人为错误，因为人为错误通常会导致剂量不足或过量。这些风险正在对止痛药输液帮浦市场的销售产生重大影响。

技术限制（例如与现有医疗保健系统和连接设备的整合）使其变得复杂、昂贵且容易受到网路威胁。此类技术错误以及相容性问题大大降低了采用率。

Acmens 按类别分类

哪个产品类别占据止痛药输液帮浦市场主导地位？

慢性病在所有年龄层（尤其是老年人）的盛行率不断上升，这就要求患者需要舒适、可自行治疗的治疗方案，从而提高患者自控镇痛泵的使用率。 。预计这项需求将有助于扩大全球市场规模。医疗保健专业人员对患者控制镇痛泵的需求日益增加，以管理患者的术后疼痛、慢性疼痛管理和分娩镇痛。

家庭医疗保健采用便携式患者控制止痛帮浦正在推动全球市场趋势。与其他类型的泵浦相比，这些设备更具成本效益，因此越来越多的患者更喜欢它们，从而推动了市场的发展。透过缩短住院时间，它将能够降低成本并实现远端监控。因此，医疗保健製造商正专注于符合监管和行业标准的患者控制止痛帮浦。

此外，随着人工智慧、MI、物联网 (IoT) 和其他先进技术的集成，这些药物传输系统将实现现代化，从而提供安全性、效率、远端监控和准确性。

哪些因素会影响居家照护产业的发展？

根据经过验证的市场研究，预计家庭护理领域将成为预测期内成长最快的领域。以患者为中心的护理和个人化治疗方案的需求日益增长，推动了止痛药输液帮浦中远端监控和远距医疗功能的整合应用。

此外，老年人和病人越来越喜欢在熟悉舒适的环境中接受治疗，这也推动了对家用医疗设备的需求。癌症、神经病变和关节炎等伴有急性疼痛的慢性疾病盛行率很高，这可能会让钱包吃不消，与长期住院相比，成本效益高的慢性疼痛管理和家庭护理的价值凸显出来。以病人为基础的照护。

由于医院面临容量课题且患者寻求尽量减少接触病毒，COVID-19 疫情加速了家庭护理服务的采用。这场疫情凸显了家庭保健的重要性，包括使用止痛药输液帮浦。

Acmens 按国家分类

哪些因素推动北美在止痛药输液帮浦市场占有领先占有率？

由于久坐的生活方式日益增加、饮食习惯和地理位置的改变，包括关节炎、下背部疼痛和神经性疼痛在内的慢性疼痛正在增加。这促使止痛药输液帮浦等疼痛管理解决方案的市场不断成长。该公司的主要重点是确保止痛药输液帮浦在推出市场之前符合严格的安全性和有效性标准，从而赢得医护人员和患者的信任。

此外，北美人口老化，更容易患慢性病，增加了对包括疼痛管理在内的医疗保健服务的需求。因此，该地区对疼痛治疗的需求为止痛药输液帮浦创造了有利可图的机会。

该地区拥有完善的医疗器材分销网络和高效的供应链。这使得止痛药输液帮浦在整个医疗保健机构中随时可用。高水准的医疗保健支出也促进了先进医疗技术的采用，包括止痛药输液泵，以改善患者护理和治疗效果。由于疼痛管理解决方案的进步，北美在止痛药输液帮浦市场保持主导地位。

对先进医疗技术日益增长的需求将如何影响亚太地区止痛药输液帮浦市场？

对先进医疗技术的需求通常与医疗专业人员和患者对这些技术的认识和理解的提高相伴而生。因此，医疗专业人员对止痛药输注帮浦在有效疼痛管理方面的益处的瞭解增加，可能会促使他们采用它们。鑑于对技术的需求，预计亚太市场在预测期内将显着增长。

对先进医疗技术日益增长的需求正在鼓励政府当局支持和投资止痛药输液泵领域的研究和开发。因此，该地区可能会开发出更为复杂、更易于使用的设备，具有增强的功能、更高的安全性和更高的药物传输精度。同样，亚太地区政府和私人医疗保健提供者在医疗保健方面的支出增加也为止痛输液帮浦市场创造了成长机会。

对止痛药输液帮浦的需求不断增长，吸引了国内外製造商进入亚太市场。竞争日益激烈，推动了新型止痛药输液泵的开发，这些输液泵具有远端监控、推注给药、与电子病历集成等功能，提高了可及性、成本效益和质量，最终可能使医疗保健受益提供者和患者。

竞争格局

受快速的技术创新和对有效疼痛管理解决方案日益增长的需求的推动，止痛药输液帮浦市场竞争激烈。市场竞争对手不断努力提高输液泵的效率、安全性和整体性能以满足不断变化的需求，从而形成了该领域的动态竞争环境。

目录

第 1 章。

市场概况
• 研究范围
• 先决条件

第 2 章执行摘要

第 3 章：经过验证的市场研究方法

• 资料探勘
• 验证
• 第一次面试
• 资料来源列表

第 4 章 止痛药输液帮浦的全球市场展望

• 概述
• 市场动态
  • 驱动程式
  • 阻碍因素
  • 机会
• 波特五力模型

第 5 章。

• 概述
• 硬脊膜外泵
• 鞘内泵
• 病人自控式止痛帮浦 (PCA)
• 其他

第六章 全球止痛药输液帮浦市场（依应用）

• 概述
• 医院
• 家庭医疗保健
• 门诊手术中心

第 7 章 全球止痛药输液帮浦市场（按地区）

• 概述
• 北美洲
  • 美国
  • 加拿大
  • 墨西哥
• 欧洲
  • 德国
  • 英国
  • 法国
  • 其他欧洲国家
  亚太地区
  • 中国
  • 日本
  • 印度
  • 其他亚太地区
• 世界其他地区
  • 拉丁美洲
  • 中东和非洲

第 8 章全球止痛药输液帮浦市场：竞争格局

• 概述
• 公司市场排名
• 主要发展策略

第九章 公司简介

• Medtronic plc
• Becton Dickinson and Company（BD）
• Braun Melsungen AG
• Fresenius Kabi AG
• Smith's Medical
• Terumo Corporation
• ICU Medical Inc.
• Roche Diagnostics（AccuVein）
• Moog Inc.
• Animas Corporation

第 10 章 重大进展

• 产品发布/开发
• 合併和收购
• 业务扩展
• 伙伴关係和合作关係

第 11 章附录

• 相关研究

Analgesic Infusion Pumps Market-Valuation-2024-2031

The Analgesic Infusion Pumps Market size was valued at USD 2.75 Billion in 2023. The Infusion Pump is a commonly used medical device for patients with chronic conditions like cancer and diabetes to overcome delivery-related problems.

The increasing prevalence of chronic pain among the elderly, a growing demand for pain management during surgical procedures, and a rising number of surgeries performed worldwide is thereby surging demand for analgesic infusion pumps. Thus, the current market will grow at a (CAGR) of around 5.3% from 2024 to 2031, reaching a market size of worthUSD 3.05 Billion by 2031.

Analgesic Infusion Pumps Market: Definition/Overview

Analgesic infusion pumps are medical devices designed to deliver pain-relieving medications directly into a patient's body. By providing a constant and precise flow of analgesics, these pumps can effectively manage pain and improve the quality of life for patients. These solutions are particularly useful in obstetric, terminally ill, postoperative, and trauma patients. The pumps can be programmed to deliver a specific dosage over a set of periods, ensuring a steady release of pain relief medication.

The increasing prevalence of chronic pain conditions such as failed back syndrome, complex regional pain syndrome (CRPS), myocardial infarction, spinal cord injury, cerebral palsy, and others, among all age groups, especially the geriatric population, is increasing demand for pain management treatments such as analgesic fusion pumps.

What's inside a VMR industry report?

Our reports include actionable data and forward-looking analysis that help you craft pitches, create business plans, build presentations and write proposals.

Which are the Drivers Encouraging Adoption of Infusion Pumps?

The prevalence of chronic pain ailments like arthritis, cancer pain, and neuropathic pain across the world among the obese, aged, or other age groups are demanding pain management options, driving demand for analgesic infusion pumps. Likewise, the demand for pain-relieving drug infusers post-surgical procedures is creating room for the Analgesic Infusion Pumps Market.

Also, continuous advancements such as precise dosage control, and remote monitoring, is all possible using smart features such as artificial intelligence, and connected health platforms to help develop a portable and user-friendly solution. Thus, the improvements in pump technology are enhancing the capabilities and user experience of analgesic infusion pumps.

Moreover, the application of effective pain management solutions such as these pumps is increasing owing to initiatives and educational campaigns offering therapeutic benefits and patient satisfaction. Awareness regarding the use of analgesic infusion pumps in home-based care and ambulatory surgical centers is increasing to shorten hospital stays and personalize pain management.

Besides these, high disposable incomes in developing economies is improving accessibility to healthcare services and advanced medical technologies like analgesic infusion pumps, driving their sales.

Despite their high costs and regulatory hurdles, the advantages of the Analgesic Infusion Pumps Market is projected to continue growing in the coming years.

Will High Costs Hinder Growth of the Analgesic Infusion Pumps Market?

The cost of development and maintenance of technologically advanced infusion pumps can be affect the adoption rate by healthcare facilities, particularly those in resource-limited or lower-income settings. This limits their ability to invest in these devices as the needle and syringe used will further add up to the overall cost, potentially hindering patient access to advanced treatment options.

The existence of stringent regulatory requirements for medical devices is likely to extend the approval and expense of the development processes, delaying market entry. This financial expense is likely to burden the manufacturers and healthcare providers.

While pumps offer advantages in some scenarios, convincing healthcare professionals and patients is challenging as alternative pain management options, like oral medications, non-invasive techniques like nerve blocks, and physical therapy are proving effective.

Also, the need for proper training is necessary to avoid human error, which is likely to cause over or underdosing. These risks are majorly impacting the sales of Analgesic Infusion Pumps Market.

The technical limitations such integration with the existing healthcare systems or connective device is complex, expensive, and prone to cyberthreats. Such technological errors along with compatibility issues plummet the adoption rate to a greater extent.

Category- Wise Acumens

Which Product Category Dominates the Analgesic Infusion Pumps Market?

The increasing prevalence of chronic diseases among all age groups, especially aged group, is demanding need for comfortable and self-administer treatment options, thereby bolstering the use of patient-controlled analgesia pumps. This demand is likely to help fuel the global market size. Healthcare professionals are increasing the demand for patient-controlled analgesia pumps to manage patients' post-operative pain, chronic pain management, and labor analgesia.

The adoption of portable patient-controlled analgesia pumps for home healthcare is driving the global market trend. Patients rising preference for these devices owing to its cost-effectiveness compared to other types of pumps is propelling the market. Its role in reducing hospital stays is enables cost-savings as well as remote monitoring. Thus, healthcare manufacturers are their focus on patient-controlled analgesic pumps in compliance with regulatory standards and industrial standards.

Furthermore, the integration of AI, MI, Internet of Things (IoT), and other advanced technologies will modernize these drug delivery systems to an extent offering safety, efficiency, remote monitoring, and accuracy.

Which Factors are Influencing the Growth of Home Care Industry?

As per Verified Market Research, home care segment is projected to experience fastest-growth over the forecast period. There is an increasing demand for patient-centric care and personalized treatment options, creating wider scope of adoption of integration of remote monitoring and telehealth capabilities in analgesic infusion pumps.

Also, a growing preference for familiar and comfortable environments for treatment among the elderly or disease-affected patients is driving the need for home-based medical devices. The high prevalence of chronic illness with acute pain such as cancer, neurological disorder, and arthritis leads to non-pocket-friendly outcomes, thereby encouraging the use of cost-effective chronic pain management or value-based care at home compared to extended hospital stays

The COVID-19 pandemic has accelerated the adoption of home care services as hospitals faced capacity challenges and patients sought to minimize exposure to the virus. The pandemic has reinforced the importance of home-based healthcare, including the use of analgesic infusion pumps.

Country/Region-wise Acumens

What Factors Enable North America Hold Major Share in Analgesic Infusion Pumps Market?

Growing adoption of a sedentary lifestyle, changing dietary habits, and geographical conditions are increasing incidences of chronic pain conditions, such as arthritis, back pain, and neuropathic pain. This creates a substantial market for pain management solutions like analgesic infusion pumps. Primarily, the focus on ensuring whether analgesic infusion pumps meet rigorous safety and efficacy standards before being introduced into the market and fostering trust among healthcare professionals and patients are factors bolstering the demand in North America.

Additionally, the aging population with higher susceptibility to chronic illnesses in North America is leading to a higher demand for healthcare services, including pain management. Thereby, the demand for pain treatment options is creating lucrative opportunities for analgesic infusion pumps in this region.

The region has well-established distribution networks and efficient supply chains for medical devices. This facilitates the easy availability and accessibility of analgesic infusion pumps across healthcare institutions. High levels of healthcare spending is also contributing to the adoption of advanced medical technologies, including analgesic infusion pumps, to improve patient care and outcomes. The advancements in pain management solutions are enabling North America to retain its dominance in the Analgesic Infusion Pumps Market.

How will Surging Demand for Advanced Medical Technologies Affect the Analgesic Infusion Pumps Market in Asia Pacific?

The demand for advanced medical technologies often goes hand-in-hand with an increased awareness and understanding of these technologies among healthcare professionals and patients. This may lead to adoption of analgesic infusion pumps as healthcare providers become more educated about their benefits in managing pain effectively. In response to this technological demand, the market enables Asia Pacific to experience substantial growth over the forecast period.

The rising demand for advanced medical technologies is driving support and investment from government authorities in the research and development in the field of analgesic infusion pumps. This may result in the development of more sophisticated and user-friendly devices with enhanced features, improved safety profiles, and greater precision in drug delivery in the region. Similarly, increasing spending on healthcare by the governments and private healthcare providers in the Asia Pacific is creating opportunities for the growth of the Analgesic Infusion Pumps Market.

The growing demand for analgesic infusion pumps is attracting both local and international manufacturers to the Asia Pacific market. This increased competition may lead to the development of new and improved analgesic infusion pumps with features, such as remote monitoring, bolus dosing, and integration with electronic health records, increasing accessibility, cost-effectiveness, and quality, and ultimately benefiting healthcare providers and patients.

Competitive Landscape

The Analgesic Infusion Pumps Market is intensely competitive, fueled by rapid technological breakthroughs and rising demand for effective pain management solutions. Market competitors are constantly striving to improve the efficiency, safety, and overall performance of infusion pumps to satisfy the changing needs, resulting in a dynamic and competitive environment within the sector.

Some of the prominent players operating in the Analgesic Infusion Pumps Market include:

Medtronic plc, Becton Dickinson and Company (BD), Braun Melsungen AG, Fresenius Kabi AG, Smith's Medical, Terumo Corporation, ICU Medical Inc., Roche Diagnostics (AccuVein), Moog Inc., Animas Corporation, Tandem Diabetes Care Inc., Micrel Medical Devices S.A. (a Mindray Company), Zyno Medical, Sensile Medical AG (a subsidiary of Gerresheimer AG), CME Medical (a BD Company), Zenith Medic (a subsidiary of Smiths Group), Q Core Medical Ltd., Ace Medical Co. Ltd., Nipro Corporation, Chemyx Inc.

Latest Developments

In August 2023, ICU Medical, Inc. (US) received FDA clearance for its Plum Duo infusion Pump, which make it available for customers in the US in early 2024.

In April 2023, Fresenius Kabi (Germany) announced that its Ivenix Infusion System has received on Innovative Technology contract from Vizient, Inc. (US), which sets terms for hospitals to evaluate and purchase the Ivenix Infusion System.

In August 2022, Becton Dickinson and company (Us) Novum IQ Syringe Infusion Pump received FDA Approval.

In March 2022, Fresenius Kabi (Germany) received US FDA approval for the wireless Agilia Connect Infusion System, which includes the Agilia Volumetric Pump and the Agilia Syringe Pump with Vigilant Software Suite-Vigilant Master Med Technology.

TABLE OF CONTENTS

1. INTRODUCTION OF GLOBAL ANALGESIC INFUSION PUMPS MARKET

• 1.1. Overview of the Market
• 1.2. Scope of Report
• 1.3. Assumptions

2. EXECUTIVE SUMMARY

3. RESEARCH METHODOLOGY OF VERIFIED MARKET RESEARCH

• 3.1. Data Mining
• 3.2. Validation
• 3.3. Primary Interviews
• 3.4. List of Data Sources

4. GLOBAL ANALGESIC INFUSION PUMPS MARKET OUTLOOK

• 4.1. Overview
• 4.2. Market Dynamics
  • 4.2.1. Drivers
  • 4.2.2. Restraints
  • 4.2.3. Opportunities
• 4.3. Porters Five Force Model

5. GLOBAL ANALGESIC INFUSION PUMPS MARKET, BY PRODUCT

• 5.1. Overview
• 5.2 Epidural Pumps
• 5.3 Intrathecal Pumps
• 5.4 Patient-Controlled Analgesia Pump (PCA)
• 5.5 Others

6. GLOBAL ANALGESIC INFUSION PUMPS MARKET, BY APPLICATION

• 6.1. Overview
• 6.2 Hospitals
• 6.3 Home Care
• 6.4 Ambulatory Surgical Centers

7. GLOBAL ANALGESIC INFUSION PUMPS MARKET, BY GEOGRAPHY

• 7.1. Overview
• 7.2. North America
  • 7.2.1. U.S.
  • 7.2.2. Canada
  • 7.2.3. Mexico
• 7.3. Europe
  • 7.3.1. Germany
  • 7.3.2. U.K.
  • 7.3.3. France
  • 7.3.4. Rest of Europe
• 7.4. Asia Pacific
  • 7.4.1. China
  • 7.4.2. Japan
  • 7.4.3. India
  • 7.4.4. Rest of Asia Pacific
• 7.5. Rest of the World
  • 7.5.1. Latin America
  • 7.5.2. Middle East & Africa

8. GLOBAL ANALGESIC INFUSION PUMPS MARKET COMPETITIVE LANDSCAPE

• 8.1. Overview
• 8.2. Company Market Ranking
• 8.3. Key Development Strategies

9. COMPANY PROFILES

• 9.1. Medtronic plc
  • 9.1.1. Overview
  • 9.1.2. Financial Performance
  • 9.1.3. Product Outlook
  • 9.1.4. Key Developments
• 9.2. Becton Dickinson and Company (BD)
  • 9.2.1. Overview
  • 9.2.2. Financial Performance
  • 9.2.3. Product Outlook
  • 9.2.4. Key Developments
• 9.3. Braun Melsungen AG
  • 9.3.1. Overview
  • 9.3.2. Financial Performance
  • 9.3.3. Product Outlook
  • 9.3.4. Key Developments
• 9.4. Fresenius Kabi AG
  • 9.4.1. Overview
  • 9.4.2. Financial Performance
  • 9.4.3. Product Outlook
  • 9.4.4. Key Developments
• 9.5. Smith's Medical
  • 9.5.1. Overview
  • 9.5.2. Financial Performance
  • 9.5.3. Product Outlook
  • 9.5.4. Key Developments
• 9.6. Terumo Corporation
  • 9.6.1. Overview
  • 9.6.2. Financial Performance
  • 9.6.3. Product Outlook
  • 9.6.4. Key Developments
• 9.7. ICU Medical Inc.
  • 9.7.1. Overview
  • 9.7.2. Financial Performance
  • 9.7.3. Product Outlook
  • 9.7.4. Key Developments
• 9.8. Roche Diagnostics (AccuVein)
  • 9.8.1. Overview
  • 9.8.2. Financial Performance
  • 9.8.3. Product Outlook
  • 9.8.4. Key Developments
• 9.9. Moog Inc.
  • 9.9.1. Overview
  • 9.9.2. Financial Performance
  • 9.9.3. Product Outlook
  • 9.9.4. Key Developments
• 9.10. Animas Corporation
  • 9.10.1. Overview
  • 9.10.2. Financial Performance
  • 9.10.3. Product Outlook
  • 9.10.4. Key Developments

10 KEY DEVELOPMENTS

• 10.1 Product Launches/Developments
• 10.2 Mergers and Acquisitions
• 10.3 Business Expansions
• 10.4 Partnerships and Collaborations

11. Appendix

• 11.1. Related Research